Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Heart Failure
Search: search_blue_button Advanced Search
Published Online
on September 28, 2009

Circulation: Heart Failure. 2009
Published online before print September 28, 2009, doi: 10.1161/CIRCHEARTFAILURE.109.881326
A more recent version of this article appeared on November 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2/6/549    most recent
CIRCHEARTFAILURE.109.881326v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Guazzi, M.
Right arrow Articles by Ross, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guazzi, M.
Right arrow Articles by Ross, A.
Related Collections
Right arrow Other heart failure

Original Article

6 Minute Walk Test and Cardiopulmonary Exercise Testing in Chronic Heart Failure: a Comparative Analysis on Clinical and Prognostic Insights

Marco Guazzi1,4; Kenneth Dickstein2; Marco Vicenzi1 and Arena Ross3

1 University of Milano, Milano, Italy;
2 University of Bergen, Stavanger, Norway;
3 Virginia Commonwealth University, Richmond, VA

* Corresponding author; email: marco.guazzi{at}unimi.it

Background—6 min walk test (6MWT) and cardiopulmonary exercise testing (CPET) are the two testing modalities most broadly used for assessing functional limitation in heart failure (HF) patients. A comprehensive comparison on clinical and prognostic validity of the two techniques has not been performed and is the aim of the present investigation.

Methods and Results—253 patients diagnosed with systolic (n=211) or diastolic (n= 42) HF (age: 61.9±10.1 NYHA class: 2.2±0.78) underwent a 6MWT and a symptom-limited CPET evaluation and were prospectively followed-up. During the four-year tracking period there were 43 cardiac-related deaths with an annual cardiac mortality rate of 8.7%. 6MWT distance correlated with CPET-derived variables (i.e., peak VO2, VO2 at anaerobic threshold and VE/VCO2 slope) and was significantly reduced in proportion with lower peak VO2 and higher VE/VCO2 slope classes and presence of an oscillatory breathing pattern (P<0.01). However, no significant differences were observed in distance covered between survivors and non-survivors (353.2±95.8 vs 338.5±76.4 meters; P=NS). At univariate and multivariate Cox proportional analysis the association of the 6MWT distance with survival was not significant either as continuous or dicotomized variable (≤ 300 meters>). Conversely, CPET-derived variables emerged as prognostic with the strongest association found for EOB (systolic HF) and VE/VCO2 slope (entire HF population and patients with a 6MWT ≤ 300 meters).

Conclusions—6MWT is confirmed to be a simple and reliable first-line test for quantification of exercise intolerance in HF patients. However, there is no supportive evidence for its use as a prognostic marker in alternative to or in conjunction with CPET-derived variables.

Key Words: exercise • heart failure • prognosis • ventilation